Total Payments
$980.54
2024 Payments
$610.29
Companies
7
Transactions
46
Medicare Patients
14,626
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$980.54 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $980.54 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $386.25 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $237.34 | 13 | $0 (2024) |
| ABBVIE INC. | $155.76 | 7 | $0 (2024) |
| Dermavant Sciences, Inc. | $119.91 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $35.42 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.90 | 1 | $0 (2021) |
| Bioventus LLC | $20.96 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $610.29 | 31 | E.R. Squibb & Sons, L.L.C. ($174.88) |
| 2023 | $263.42 | 10 | Amgen Inc. ($213.01) |
| 2022 | $51.39 | 2 | E.R. Squibb & Sons, L.L.C. ($30.43) |
| 2021 | $55.44 | 3 | Amgen Inc. ($30.54) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.69 | General |
| Category: Immunology | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Inflammation | ||||||
| 06/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Inflammation | ||||||
| 06/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Immunology | ||||||
| 05/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: DERMATOLOGY | ||||||
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.98 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Inflammation | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.60 | General |
| Category: Immunology | ||||||
| 04/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.59 | General |
| Category: Immunology | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.71 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 4,053 | 20,669 | $1.8M | $492,180 |
| 2022 | 23 | 4,118 | 15,345 | $1.6M | $471,080 |
| 2021 | 22 | 3,391 | 14,769 | $1.3M | $402,269 |
| 2020 | 26 | 3,064 | 11,425 | $960,185 | $284,541 |
Total Patients
14,626
Total Services
62,208
Medicare Billing
$1.7M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 637 | 2,149 | $456,663 | $141,860 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 639 | 1,964 | $297,055 | $112,138 | 37.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 486 | 12,193 | $377,983 | $56,314 | 14.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 516 | 1,773 | $243,788 | $42,210 | 17.3% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 222 | 336 | $67,082 | $25,975 | 38.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 237 | 409 | $92,025 | $25,178 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 341 | 614 | $54,953 | $22,364 | 40.7% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 163 | 233 | $53,823 | $15,073 | 28.0% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 169 | 225 | $38,250 | $12,039 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 171 | 171 | $34,200 | $10,377 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 72 | $11,520 | $6,071 | 52.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 129 | 129 | $19,511 | $4,889 | 25.1% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 99 | 122 | $22,875 | $4,730 | 20.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 24 | 47 | $11,750 | $4,051 | 34.5% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 70 | 86 | $16,125 | $3,067 | 19.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 26 | $5,590 | $1,943 | 34.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 36 | 37 | $5,328 | $1,690 | 31.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 19 | 19 | $4,275 | $1,273 | 29.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 23 | 31 | $3,294 | $909.35 | 27.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 33 | $660.00 | $26.64 | 4.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 588 | 1,708 | $362,950 | $117,277 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 581 | 1,554 | $235,043 | $91,221 | 38.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 483 | 1,550 | $213,125 | $45,811 | 21.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 428 | 7,285 | $225,835 | $33,231 | 14.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 248 | 428 | $96,300 | $27,743 | 28.8% |
About Peter Wolff, NP
Peter Wolff, NP is a Family healthcare provider based in Lancaster, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720554884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Wolff, NP has received a total of $980.54 in payments from pharmaceutical and medical device companies, with $610.29 received in 2024. These payments were reported across 46 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($980.54).
As a Medicare-enrolled provider, Wolff has provided services to 14,626 Medicare beneficiaries, totaling 62,208 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Lancaster, CA
- Active Since 10/16/2018
- Last Updated 10/16/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720554884
Products in Payments
- Otezla (Drug) $386.25
- Sotyktu (Drug) $237.34
- SKYRIZI (Biological) $155.76
- VTAMA (Drug) $119.91
- TREMFYA (Drug) $35.42
- Ilumya (Biological) $24.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lancaster
Heidi Kling-Newnam, Crnp, CRNP
Family — Payments: $13,161
Family $13,161
Jessica Pfeifer, Fnp, FNP
Family — Payments: $10,485
Family $10,485
Brandi Zimmerman, Crnp, CRNP
Family — Payments: $8,985
Family $8,985
Leanne Schimke, Crnp, CRNP
Family — Payments: $7,721
Family $7,721
Christien Olewniczak, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $7,643
Family $7,643
Naomi Asamoah-Beaufait, Fnp, FNP
Family — Payments: $6,924
Family $6,924